Bayer HealthCare

November 25, 2015May 12, 2016

Bayer Survey Finds Doctors Ill-informed of a Chronic Lung Disease

A recent survey found that many primary care physicians are unfamiliar with chronic thromboembolic pulmonary hypertension (CTEPH) and slow to refer CTEPH patients to specialists, although the disease is treatable and potentially curable. The ... Read more

May 19, 2015November 5, 2015

Bayer Presents New Research on Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension at 2015 ATS Annual Conference

News, Pulmonary Hypertension

During the 2015 Annual International Conference of the American Thoracic Society (ATS), Bayer HealthCare is presenting recent research on chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). The conference is taking ... Read more

May 15, 2015November 5, 2015

Nurse Patricia Middings Wins Bayer’s Breathless Moments CTEPH Contest

News, Pulmonary Hypertension

Bayer recently announced the winner of Breathless Moments, a photography contest designed to raise awareness of chronic thromboembolic pulmonary hypertension (CTEPH) by showcasing sights, inspirational events or moments that can take someone’s breath ... Read more

January 16, 2015November 6, 2015

Ciprofloxacin Dry Powder for Inhalation Tested in Bronchiectasis

Bronchiectasis, News

Bayer and Novartis, two leading pharmaceutical companies, are developing ciprofloxacin dry powder for inhalation (DPI, brand name Cipro Inhale) to treat non-cystic fibrosis bronchiectasis. A phase 2 clinical trial, “Evaluation ... Read more

December 2, 2014November 6, 2015

Bayer’s Non-cystic Fibrosis Bronchiectasis, Pneumonia Drugs Gain QIDP Status From FDA

Bronchiectasis, News

Recently, two Bayer experimental drugs, Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation (DPI), were granted the title of qualified infectious disease products (QIDP) by the U.S. Food and Drug Administration ... Read more

November 25, 2014November 5, 2015

UC San Diego Health System Receives Launches National Chronic Thromboembolic Pulmonary Hypertension Registry

News, Pulmonary Hypertension

UC San Diego Health System is launching the first national chronic thromboembolic pulmonary hypertension (CTEPH) registry to improve healthcare practices and patient care for those with the disease, thanks to ... Read more

November 21, 2014November 5, 2015

Photo Contest Launched on First Annual CTEPH Awareness Day by Bayer

News, Pulmonary Hypertension

Bayer HealthCare Pharmaceuticals is launching an awareness and patient support campaign to support those suffering from chronic thromboembolic pulmonary hypertension (CTEPH), a type of pulmonary hypertension (PH) that provokes blood clots in the ... Read more

November 17, 2014November 6, 2015

PH Therapy Riociguat To Be Tested as Diffuse Cutaneous Systemic Sclerosis Drug

News, Scleroderma

Bayer HealthCare recently announced the launch of a new clinical trial, the RISE-SSc study, a randomized, double-blind, placebo-controlled Phase II study to investigate the efficacy and safety of riociguat against placebo in ... Read more

July 1, 2014November 6, 2015

Bayer Gains Orphan Drug Status For Ciprofloxacin To Treat Non Cystic Fibrosis Bronchiectasis

Bronchiectasis, News

Bayer HealthCare’s Ciprofloxacin Dry Powder for Inhalation, a treatment for non-cystic fibrosis bronchiectasis (NCFB), was recently granted orphan drug designation by the U.S Food and Drug Administration’s (FDA) Office of Orphan ... Read more